Check Hep C Patient Navigation Program
The goal of the Check Hep C Patient Navigation Program is to link NYC residents living with hepatitis C (Hep C) to medical care. Patient Navigators support patients to complete Hep C medical evaluation and successful Hep C treatment, prevent re-infection, and maintain liver health after treatment. This program is funded by New York City Council and private institutions, and is administered by the NYC Health Department.
Start here
- General information about Check Hep C — hep@health.nyc.gov
- To enroll or refer a patient, see the site contacts below
- More Hep C services in NYC — Find Testing & Care
Program services
Check Hep C Patient Navigators provide the following services at no cost to the patient: Hep C health promotion, referrals to supportive services, linkage to Hep C medical care, accompaniment to or reminders for medical appointments, alcohol and drug counseling, case conferencing, treatment readiness and adherence support, and medication access support.
To be eligible, patients must reside in NYC and have a positive hepatitis C RNA test result.
Note: Hep C antibody positive patients not tested for Hep C RNA are accepted at select syringe exchange programs, marked below.
Program sites & contact
To enroll in the program, refer a patient, or for more information, contact:
The Bronx
4 sitesBOOM!Health
Community Health Care Network – Bronx Health Center
Montefiore – Comprehensive Health Care Center
Urban Health Plan
Brooklyn
7 sitesBed-Stuy Family Health Center
Brownsville Multi-Service Family Health Center
Community Healthcare Network – CABS Health Center
South Brooklyn Health
Family Services Network of New York, Inc.
Accepts Hep C antibody positive patients
Interfaith Medical Center
Kings County Hospital
Manhattan
2 sitesAlliance LES Harm Reduction Center
Accepts Hep C antibody positive patients
Bellevue Hospital Center: Hepatitis Clinic
Queens
2 sitesCommunity Healthcare Network – Family Health Center
Staten Island
1 siteCommunity Health Action of Staten Island
Accepts Hep C antibody positive patients